Jin Medical International Ltd
ZJYL0.209USD
+0.001+0.29%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
32.69MMarket Cap
18.24P/E TTM
More Details of Jin Medical International Ltd Company
Jin Medical International Ltd is a holding company mainly engaged in the design and manufacturing of wheelchairs. The Company, through its wholly owned subsidiaries, is primarily engaged in the design, development, manufacturing and sales of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The Company's wheelchair product category includes mid, high and low-end wheelchairs. The wheelchair components include wheels and brakes, which are sold to customers for after-sales service. The living aids product category consists of oxygen concentrators, bath aids and rehabilitative devices. The Company mainly distributes its products in domestic and overseas markets.
Jin Medical International Ltd Info
Ticker SymbolZJYL
Company nameJin Medical International Ltd
IPO dateMar 28, 2023
CEOWang (Erqi)
Number of employees269
Security typeOrdinary Share
Fiscal year-endMar 28
AddressNo. 33 Lingxiang Road, Wujin District
CityCHANGZHOU
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryChina
Postal code213149
Phone8651989607972
Website
Ticker SymbolZJYL
IPO dateMar 28, 2023
CEOWang (Erqi)
Company Executives of Jin Medical International Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Ziqiang Wang
Mr. Ziqiang Wang
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Oliver St. Clair Franklin
Mr. Oliver St. Clair Franklin
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Jourdan Frain
Mr. Jourdan Frain
Independent Director Nominee
Independent Director Nominee
--
--
Ms. Yanru Guo
Ms. Yanru Guo
Independent Director
Independent Director
--
--
Mr. Erqi Wang
Mr. Erqi Wang
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Ziqiang Wang
Mr. Ziqiang Wang
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Oliver St. Clair Franklin
Mr. Oliver St. Clair Franklin
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Jourdan Frain
Mr. Jourdan Frain
Independent Director Nominee
Independent Director Nominee
--
--
Ms. Yanru Guo
Ms. Yanru Guo
Independent Director
Independent Director
--
--
Mr. Erqi Wang
Mr. Erqi Wang
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Wheelchair
14.87M
63.26%
Wheelchair components and others
8.64M
36.74%
By RegionUSD
Name
Revenue
Proportion
Overseas market
14.89M
63.36%
China
8.61M
36.64%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Wheelchair
14.87M
63.26%
Wheelchair components and others
8.64M
36.74%
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Jolly Harmony Enterprises Ltd
60.93%
Er Pu International Ltd
7.50%
Gorgeous Abundant Enterprises Ltd
7.41%
Geode Capital Management, L.L.C.
0.07%
UBS Financial Services, Inc.
0.03%
Other
24.07%
Shareholders
Shareholders
Proportion
Jolly Harmony Enterprises Ltd
60.93%
Er Pu International Ltd
7.50%
Gorgeous Abundant Enterprises Ltd
7.41%
Geode Capital Management, L.L.C.
0.07%
UBS Financial Services, Inc.
0.03%
Other
24.07%
Shareholder Types
Shareholders
Proportion
Corporation
75.84%
Investment Advisor/Hedge Fund
0.07%
Investment Advisor
0.05%
Hedge Fund
0.01%
Venture Capital
0.01%
Other
24.02%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
30
699.59K
0.45%
-2.00M
2025Q2
33
119.73M
76.48%
-1.91M
2025Q1
33
119.73M
76.48%
-1.91M
2024Q4
32
120.65M
77.07%
-1.01M
2024Q3
32
120.51M
76.98%
-557.84K
2024Q2
30
119.95M
76.62%
-289.15K
2024Q1
26
119.50M
76.41%
+579.31K
2023Q4
14
129.79M
83.73%
+128.79M
2023Q3
12
130.08M
83.92%
+129.42M
2023Q2
6
130.21M
84.00%
+129.73M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Jolly Harmony Enterprises Ltd
95.38M
60.93%
--
--
Jan 14, 2025
Er Pu International Ltd
11.74M
7.5%
--
--
Jan 14, 2025
Gorgeous Abundant Enterprises Ltd
11.60M
7.41%
--
--
Jan 14, 2025
Geode Capital Management, L.L.C.
106.54K
0.07%
--
--
Jun 30, 2025
UBS Financial Services, Inc.
93.83K
0.06%
-76.71K
-44.98%
Jun 30, 2025
Osaic Holdings, Inc.
22.40K
0.01%
+2.95K
+15.17%
Jun 30, 2025
Millennium Management LLC
68.24K
0.04%
-68.33K
-50.03%
Jun 30, 2025
HRT Financial LP
11.98K
0.01%
+11.98K
--
Jun 30, 2025
Tower Research Capital LLC
12.33K
0.01%
+4.69K
+61.43%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Vanguard Total World Stock Index Fund
0%
Vanguard ESG International Stock ETF
0%
Invesco Golden Dragon China ETF
0%
Vanguard Total World Stock Index Fund
Proportion0%
Vanguard ESG International Stock ETF
Proportion0%
Invesco Golden Dragon China ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Feb 07, 2024
Split
1→20
Date
Type
Ratio
Feb 07, 2024
Split
1→20
FAQs
Who are the top five shareholders of Jin Medical International Ltd?
The top five shareholders of Jin Medical International Ltd are:
Jolly Harmony Enterprises Ltd holds 95.38M shares, accounting for 60.93% of the total shares.
Er Pu International Ltd holds 11.74M shares, accounting for 7.50% of the total shares.
Gorgeous Abundant Enterprises Ltd holds 11.60M shares, accounting for 7.41% of the total shares.
Geode Capital Management, L.L.C. holds 106.54K shares, accounting for 0.07% of the total shares.
UBS Financial Services, Inc. holds 93.83K shares, accounting for 0.06% of the total shares.
Jolly Harmony Enterprises Ltd holds 95.38M shares, accounting for 60.93% of the total shares.
Er Pu International Ltd holds 11.74M shares, accounting for 7.50% of the total shares.
Gorgeous Abundant Enterprises Ltd holds 11.60M shares, accounting for 7.41% of the total shares.
Geode Capital Management, L.L.C. holds 106.54K shares, accounting for 0.07% of the total shares.
UBS Financial Services, Inc. holds 93.83K shares, accounting for 0.06% of the total shares.
What are the top three shareholder types of Jin Medical International Ltd?
The top three shareholder types of Jin Medical International Ltd are:
Jolly Harmony Enterprises Ltd
Er Pu International Ltd
Gorgeous Abundant Enterprises Ltd
Jolly Harmony Enterprises Ltd
Er Pu International Ltd
Gorgeous Abundant Enterprises Ltd
How many institutions hold shares of Jin Medical International Ltd (ZJYL)?
As of 2025Q3, 30 institutions hold shares of Jin Medical International Ltd, with a combined market value of approximately 699.59K, accounting for 0.45% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -76.03%.
What is the biggest source of revenue for Jin Medical International Ltd?
In FY2024, the Wheelchair business generated the highest revenue for Jin Medical International Ltd, amounting to 14.87M and accounting for 63.26% of total revenue.
